M55551

Factor Xa inhibitor; structure in first source

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

1.	Thrombosis (Thrombus) 01/04/2006 - "Intravenous administration of M55551 and oral administration of M55165 inhibited thrombus formation at 0.3 mg/kg and 10 mg/kg, respectively, without significant prolongation of bleeding time. " 01/04/2006 - "These results suggest that M55551 and M55165 are potent factor Xa inhibitors that are active upon intravenous and oral administration, respectively, and that may prove clinically useful for the treatment of thrombosis while minimizing bleeding risks."
2.	Hemorrhage 01/04/2006 - "These results suggest that M55551 and M55165 are potent factor Xa inhibitors that are active upon intravenous and oral administration, respectively, and that may prove clinically useful for the treatment of thrombosis while minimizing bleeding risks."

1.	Oral Administration
2.	Intravenous Administration